'''DEFINITELY NEED TO MAKE THIS SHORTER AND ANNOTATE THE GRAPHIC'''
This system relies on two interacting mRNA transcripts, both of which would ordinary be translated into a reporter (a fluorescent protein in our case) in the presence of a particular substrate. The idea being that these transcripts will only be made in the presence of certain substrates due to differing promoter activity. Two promoters with overlapping specificity would be used and, crucially, if both promoters detect the same substrates but differ in that one extra substrate is detected by one of the promoters, it is this substrate and this substrate only that our system will be able to detect in a simple and quantitative way.
This system relies on two interacting mRNA transcripts, both of which would ordinary be translated into a reporter (a fluorescent protein in our case) in the presence of a particular substrate. The idea being that these transcripts will only be made in the presence of certain substrates due to differing promoter activity. Two promoters with overlapping specificity would be used and, crucially, if both promoters detect the same substrates but differ in that one extra substrate is detected by one of the promoters, it is this substrate and this substrate only that our system will be able to detect in a simple and quantitative way.
Sensory BioBrick systems have been a large constituent of previous iGEM projects, in which teams have combined impressive amounts of logic with limitless creativity to produce synthetically engineered organisms with the potential of detecting the presence of a substrate within its environment via innovative combinations of various promoter and reporter BioBricks. Our project comprised of 3 novel systems aims to revolutionise the way sensory systems work.
Our own hybrid promoter hopes to add to the systems already in the registry by creating a hybrid promoter that combines the bacterial promoter PyeaR and the mammalian CArG element , both of which respond to exogenous nitrogenous species. Combining the two would allow a more modular NO sensor that can be used in mammalian and bacterial cells interchangeably.
. Flexible and has two orientations
. Six biobricks out of it
. Characterised with fluorescent proteins
. Data from flow cytometry, fluorometers, FACS
. Transfected into mammalian cells for further testing
DEFINITELY NEED TO MAKE THIS SHORTER AND ANNOTATE THE GRAPHIC
This system relies on two interacting mRNA transcripts, both of which would ordinary be translated into a reporter (a fluorescent protein in our case) in the presence of a particular substrate. The idea being that these transcripts will only be made in the presence of certain substrates due to differing promoter activity. Two promoters with overlapping specificity would be used and, crucially, if both promoters detect the same substrates but differ in that one extra substrate is detected by one of the promoters, it is this substrate and this substrate only that our system will be able to detect in a simple and quantitative way.
Our system relies on two constructs that interact via complimentary base pair sequences both before and after the ribosome binding site of the reporter protein. The idea being that, when both transcripts are present in the chassis, they would bind together, inhibiting the translation of the reporter proteins. Any imbalance of transcription due to the presence of the substrate of interest results in free mRNA of the gene system that detects that substrate.
Our team have constructed a countercurrent comparator circuit in which the reporter proteins are at the same end of the complimentary region, although a contracurrent system has been theorised. Both systems share a crucial subtractive nature comparable to an analogue computer. We envisage that, should the system be fine-tuned and expanded on, a variety of different business sectors from agriculture to spinoff pharmaceutical companies (such as the fictious QuantaCare) could capitalise on this novel genetic technology.
Assembling the various gene constructs was not without its challenges. The construction of complimentary ‘zips’ within the sequence that surrounded and, in the case of the contracurrent comparator circuit, included the ribosome binding site it was often the case that the DNA sequence would form unwanted secondary structures. When designing the DNA we took care to avoid these structures obstructing sequences required for translation of the mRNA and, at the same time, only using codons that we know are not rare in E. coli and that code for an amino acid that is unlikely to change the function of the protein produced. This is required since the zip sequences extend past the translational start codon, thus our construct will add a small N-terminal tag to the reporter protein.
Due to the stop codon present in the scars of Assembly Standard 10 BioBricks, we decided that our constructs would have to be an Assembly Standard 23 BioBrick. Although the use of Bioscaffolds produced by previous iGEM teams was considered, time constraints meant that changing the Assembly Standard we put our BioBricks in would be the most convenient solution.
The two gene constructs for the comparator circuit are currently being synthesised, and we look forward to receiving the synthetic gene soon and being able to characterise it!
Warrior Cell
A problem with current cancer therapeutic techniques is that they are not specific to cancer cells, leading to
patient discomfort. We hope to engineer E.coli cells that selectively identifies cancerous cells through their
anaerobic environment and secrete high concentrations of NO, mimicking macrophages, and thus killing
these cells. These cells are known to be hypoxic, and hypoxia is a hallmark for cancer cells already used in
tumour detection. Our Warrior Cell construct hopes to pave the way for a new kind of therapeutic strategy
that delivers a therapeutic agent only when and where it is needed.
"
